Preclinical development of SENTI-202, an off-the-shelf Logic Gated CAR-NK cell therapy, for the treatment of CD33/FLT3+ hematologic malignancies including AML

Alba Gonzalez, Enping Hong, GozdeYucel, Elizabeth Leitner, PearleyChinta, Han Deng, Ian Li, Alice Lam, AblaBakir, Brandon Lee, PapiaChakraborty, Carmina Blanco, Chen-Ting Lee, NiranAlmudhfar, MengxiTian, WenqiSong, Andrew Banicki, Otto Contreras, Martin Gieldin, Brian Garrison, Timothy K. Lu, Kanya Rajangam

View PDF